TransMedics Group, Inc. (BIT:1TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,796	2,021	2,331	1,844	468	442
Market Cap Growth	-16.62%	-13.30%	26.45%	294.09%	5.88%	25.50%
Enterprise Value	3,898	2,203	2,411	1,716	408	362
PE Ratio	62.21	59.01	-	-	-	-
PS Ratio	8.39	4.74	10.67	21.08	17.58	21.08
PB Ratio	14.02	9.15	18.78	10.52	7.84	5.20
P/TBV Ratio	15.00	9.74	20.97	10.52	7.84	5.20
P/OCF Ratio	38.67	42.88	-	-	-	-
EV/Sales Ratio	8.55	5.17	11.03	19.62	15.34	17.25
EV/EBITDA Ratio	42.48	39.83	307.71	-	-	-
EV/EBIT Ratio	59.30	60.82	5495.72	-	-	-
Debt / Equity Ratio	1.63	2.27	3.76	0.36	0.65	0.33
Debt / EBITDA Ratio	4.85	8.19	38.35	-	-	-
Asset Turnover	0.64	0.59	0.49	0.45	0.21	0.20
Inventory Turnover	4.64	3.95	2.70	1.59	0.68	0.78
Quick Ratio	8.93	7.25	8.34	9.67	4.23	11.16
Current Ratio	9.86	8.30	9.30	10.66	5.11	12.36
Return on Equity (ROE)	28.21%	19.39%	-15.42%	-28.39%	-51.49%	-36.27%
Return on Assets (ROA)	5.80%	3.10%	0.06%	-9.54%	-17.18%	-12.82%
Return on Capital (ROIC)	6.20%	3.35%	0.07%	-10.72%	-19.70%	-14.51%
Return on Capital Employed (ROCE)	9.20%	5.00%	0.10%	-	-	-
Earnings Yield	1.61%	1.70%	-0.97%	-1.84%	-8.31%	-5.32%
FCF Yield	0.39%	-3.87%	-6.40%	-2.93%	-6.09%	-5.68%
Buyback Yield / Dilution	-11.94%	-8.30%	-10.02%	-7.02%	-11.80%	-73.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.